The invention relates generally to devices that are retained inside a body passage and in one particular application to vascular devices used in repairing arterial dilations, e.g., aneurysms. More particularly, the invention is directed toward devices that can be adjusted during deployment, thereby allowing at least one of a longitudinal or radial re-positioning of the device.
The invention will be discussed generally with respect to deployment of a bifurcated stent graft into the abdominal aorta but is not so limited and may apply to device deployment into other body lumens. When delivering a stent graft by intraluminal or endovascular methods, it is important to know the precise location of the device in the vasculature. Controlling this precise location is particularly important when the device is intended to be deployed in close proximity to branch vessels or adjacent to weakened portions of the aortic wall. Typical stent grafts used to repair an aortic aneurysm incorporate a proximal (i.e. portion of the stent graft closest to the heart) anchoring system intended to limit longitudinal displacement of the stent graft. Often this anchoring system must be precisely placed to avoid occlusion of a branch vessel or to avoid placement within a compromised and damaged portion of the aortic wall.
An improved delivery system for such stent grafts would include a means for allowing precise longitudinal and rotational placement of the stent graft and anchoring system. The precise position of the stent graft and anchoring system would be adjusted and visualized prior to full deployment of the device. Ideally the delivery system would allow the device to be repositioned if the prior deployment position was undesirable.
The present invention is directed to a controlled deployable medical device and method of making the same that substantially obviates one or more of the problems due to limitations and disadvantages of the related art.
An embodiment of the present invention provides an apparatus, comprising a catheter having a proximal end portion and distal end portion. A hub can be arranged on a distal end portion of the catheter. A stent member is arranged on the proximal end portion of the catheter, the stent member has an inner surface and an outer surface. The stent can be configured in any suitable manner. In an embodiment of the invention, the stent is configured from multiple turns of an undulating element. Such a stent member can have substantially in-phase undulations. A graft member can be arranged about the stent member. Moreover, an element can be connected to a torsional member, wherein the torsional member is capable of retracting a portion of the element and thereby radially compressing at least a portion of the stent.
In another embodiment, the present invention provides an apparatus substantially as described above, further comprising a tube having a proximal end portion and distal end portion arranged on at least a portion of the substantially tubular shaped stent member, wherein at least a portion of the torsional member extends within a portion of the tube.
The accompanying drawings are included to provide a further understanding of the invention and illustrate certain aspects of the invention.
In the drawings:
The invention relates generally to a novel medical apparatus that includes a device capable of being retained inside a body passage and in one particular application to vascular devices. More particularly, the invention is directed toward devices that can be adjusted during deployment, thereby allowing at least one of a longitudinal or radial re-positioning. The term distal as used herein denotes a position furthest from the heart, while the term proximal denotes a position closest to the heart.
In an embodiment of the invention, the medical apparatus includes a catheter assembly having a proximal end portion and distal end portion. A hub can be optionally arranged on a distal end portion of the catheter assembly. A stent is arranged on a proximal end portion of the catheter. A graft member can be arranged about at least a portion of the stent. The stent may be self-expandable, balloon-expandable or a combination of self-expandable and balloon-expandable.
In some embodiments, the stents can be used to fix the medical apparatus inside a portion of a patient's anatomy. The stent can be preferably constructed from materials that are flexible and strong. The stent can be formed from degradable bioabsorable materials, biodigestible materials, polymeric materials, metallic materials and combinations thereof. In addition, these materials may be reinforced and/or coated with other materials, such as polymeric materials and the like. The coating may be chosen to reduce acidic or basic effects of the gastrointestinal tract, e.g., with a thermoplastic coating such as ePTFE and the like.
More specifically, the stents can be fabricated according to the methods and materials as generally disclosed in, for example, U.S. Pat. No. 6,042,605 issued to Martin, et al., U.S. Pat. No. 6,361,637 issued to Martin, et al. and U.S. Pat. No. 6,520,986 issued to Martin, et al. For example, stents can have various configurations as known in the art and can be fabricated, for example, from cut tubes, wound wires (or ribbons), flat patterned sheets rolled into a tubular form, combinations thereof, and the like. Stents can be formed from metallic, polymeric or natural materials and can comprise conventional medical grade materials such as nylon, polyacrylamide, polycarbonate, polyethylene, polyformaldehyde, polymethylmethacrylate, polypropylene, polytetrafluoroethylene, polytrifluorochlorethylene, polyvinylchloride, polyurethane, elastomeric organosilicon polymers; metals such as stainless steels, cobalt-chromium alloys and nitinol and biologically derived materials such as bovine arteries/veins, pericardium and collagen. Stents can also comprise bioresorbable materials such as poly(amino acids), poly(anhydrides), poly(caprolactones), poly(lactic/glycolic acid) polymers, poly(hydroxybutyrates) and poly(orthoesters).
The stents can be formed into a variety of different geometric configurations having constant and/or varied thickness as known in the art. The geometric configurations may include many conventional stent configurations such as a helically wrapped stent, z-shape stent, tapered stent, coil stent, combinations thereof, and the like. The stents can be formed in a variety of patterns, such as, a helix pattern, ring pattern, combinations thereof, and the like.
Grafts can have various configurations as known in the art and can be fabricated, for example, from tubes, sheets or films formed into tubular shapes, woven or knitted fibers or ribbons or combinations thereof. Graft materials can include, for example, conventional medical grade materials such as nylon, polyester, polyethylene, polypropylene, polytetrafluoroethylene, polyvinylchloride, polyurethane and elastomeric organosilicone polymers.
Stents can be used alone or in combination with graft materials. Stents can be configured on the external or internal surface of a graft or may be incorporated into the internal wall structure of a graft. Stent or stent grafts can be delivered endoluminally by various catheter based procedures known in the art. For example self-expanding endoluminal devices can be compressed and maintained in a constrained state by an external sheath. The sheath can be folded to form a tube positioned external to the compressed device. The sheath edges can be sewn together with a deployment cord that forms a “chain stitch”. To release and deploy the constrained device, one end of the deployment cord can be pulled to disrupt the chain stitch, allowing the sheath edges to separate and release the constrained device. Constraining sheaths and deployment cord stitching can be configured to release a self-expanding device in several ways. For example a constraining sheath may release a device starting from the proximal device end, terminating at the distal device end. In other configurations the device may be released starting from the distal end. Self-expanding devices may also be released from the device center as the sheath disrupts toward the device distal and proximal ends.
Details relating to constraining sheath materials, sheath methods of manufacture and stent graft compression techniques can be found in, for example, U.S. Pat. No. 6,352,561 issued to Leopold, et al., and U.S. Pat. No. 6,551,350 issued to Thornton, et al.
The catheter and hub assemblies can comprise conventional medical grade materials such as nylon, polyacrylamide, polycarbonate, polyethylene, polyformaldehyde, polymethylmethacrylate, polypropylene, polytetrafluoroethylene, polytrifluorochlorethylene, polyether block amide or thermoplastic copolyether, polyvinylchloride, polyurethane, elastomeric organosilicone polymers, and metals such as stainless steels and nitinol.
Turning to the figures,
Referring to
The stent 104 has a proximal end portion 106 and distal end portion 108. The distal end portion 108 is formed into a branch having a first leg 110 and a second leg 112.
A graft member 114 is arranged about the stent 104.
In an embodiment of the invention, the stent 104 and graft member 114 are constrained into a compacted delivery state by a first sheath 116 and second sheath 118. As shown in
A torsional member 120 extends from a proximal end portion to a distal end portion of the catheter assembly 102. In the figure, the torsional member 120 is positioned adjacent the outer surface of the stent 104 and graft 114. The torsional member 120 is attached to the catheter assembly 102 and not attached to the stent 104 or graft 114. A movable element 122 having a first end 124 and second end 126 surrounds the stent 104 and graft member 114. The first end 124 and second end 126 of the movable element 122 extend out a distal end portion of the torsional member 120. For example, the movable element 122 is threaded through the tube from a distal end to a proximal end and is looped around the proximal end portion 106 of the stent 104 and graft member 114.
As shown in
Referring to
A torsional member 120 extends from a proximal end portion to a distal end portion of the catheter assembly. The torsional member 120 is positioned internal to the stent 104 and graft 114. The torsional member 120 is attached to the catheter assembly and not attached to the stent 104 or graft 114. A movable element 122 having a first end 124 and second end 126 is looped through and around the stent 104 and graft member 114. The first end 124 and second end 126 of the movable element 122 extend out a distal end portion of the torsional member 120. For example, the movable element 122 is threaded through the tube from a distal end to a proximal end and is looped around the proximal end portion of the stent 104 and graft member 114. As shown in
Referring to
Shown in
Shown in
Referring to
The stent 104 has a proximal end portion 106 and distal end portion 108. The distal end portion 108 is formed into a branch having a first leg 110 and a second leg 112.
A graft member 114 is arranged about the stent 104.
The stent 104 and graft member 114 are constrained into a compacted delivery state by a first sheath 116 and second sheath 118. As shown in
Shown in
Shown in
It will be apparent to those skilled in the art that various modifications and variation can be made in the present invention without departing from the spirit or scope of the invention. Thus, it is intended that the present invention cover the modifications and variations of this invention provided they come within the scope of the appended claims and their equivalents.
This application is a continuation of U.S. patent application Ser. No. 14/531,697, filed Nov. 3, 2014, now U.S. Pat. No. 9,907,683, issued Mar. 6, 2018, which is a continuation of U.S. patent application Ser. No. 12/478,245, filed Jun. 4, 2009, which claims the benefit of Provisional Application No. 61/058,770, filed Jun. 4, 2008, all of which are incorporated herein by reference in their entireties for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
4738666 | Fuqua | Apr 1988 | A |
5035706 | Giantureo et al. | Jul 1991 | A |
5387235 | Chuter | Feb 1995 | A |
5405378 | Strecker | Apr 1995 | A |
5464449 | Ryan | Nov 1995 | A |
5554183 | Nazari | Sep 1996 | A |
5643279 | Trotta | Jul 1997 | A |
5662702 | Keranen | Sep 1997 | A |
5683451 | Lenker | Nov 1997 | A |
5693083 | Baker et al. | Dec 1997 | A |
5713948 | Ulfacker | Feb 1998 | A |
5776186 | Uflacker | Jul 1998 | A |
5800521 | Orth | Sep 1998 | A |
5824055 | Spiridigliozzi | Oct 1998 | A |
5843158 | Lenker | Dec 1998 | A |
5957929 | Brenneman | Sep 1999 | A |
6019785 | Strecker | Feb 2000 | A |
6042605 | Martin et al. | Mar 2000 | A |
6051001 | Borghi | Apr 2000 | A |
6168616 | Brown | Jan 2001 | B1 |
6235051 | Murphy | May 2001 | B1 |
6245097 | Inoue | Jun 2001 | B1 |
6251132 | Ravenscroft | Jun 2001 | B1 |
6270520 | Inoue | Aug 2001 | B1 |
6280464 | Hayashi | Aug 2001 | B1 |
6287315 | Wijeratne | Sep 2001 | B1 |
6302891 | Nadal | Oct 2001 | B1 |
6352561 | Leopold et al. | Mar 2002 | B1 |
6361637 | Martin | Mar 2002 | B2 |
6371979 | Beyar | Apr 2002 | B1 |
6416536 | Yee | Jul 2002 | B1 |
6520986 | Martin | Feb 2003 | B2 |
6533811 | Ryan | Mar 2003 | B1 |
6537284 | Inoue | Mar 2003 | B1 |
6551350 | Thornton et al. | Apr 2003 | B1 |
6558396 | Inoue | May 2003 | B1 |
6565597 | Fearnot | May 2003 | B1 |
6656212 | Ravenscroft | Dec 2003 | B2 |
6676692 | Rabkin | Jan 2004 | B2 |
6723116 | Taheri | Apr 2004 | B2 |
6733521 | Chobotov et al. | May 2004 | B2 |
6740111 | Lauterjung | May 2004 | B1 |
6776791 | Stallings | Aug 2004 | B1 |
6821291 | Bolea | Nov 2004 | B2 |
6837901 | Rabkin | Jan 2005 | B2 |
6852116 | Leonhardt et al. | Feb 2005 | B2 |
6855159 | Tanner | Feb 2005 | B1 |
6916335 | Inoue | Jul 2005 | B2 |
6945990 | Greenan | Sep 2005 | B2 |
6984244 | Perez et al. | Jan 2006 | B2 |
7074235 | Roy | Jul 2006 | B1 |
7226473 | Brar et al. | Jun 2007 | B2 |
7803177 | Hartley et al. | Sep 2010 | B2 |
7993383 | Hartley et al. | Aug 2011 | B2 |
8043356 | Kolbel | Oct 2011 | B2 |
8252037 | Styrc et al. | Aug 2012 | B2 |
8361137 | Perouse | Jan 2013 | B2 |
8845709 | Styrc et al. | Sep 2014 | B2 |
9107771 | Wubbeling et al. | Aug 2015 | B2 |
9198787 | Kratzberg | Dec 2015 | B2 |
9314355 | Styrc | Apr 2016 | B2 |
9375308 | Norris | Jun 2016 | B2 |
9427317 | Styrc | Aug 2016 | B2 |
9907683 | Zukowski et al. | Mar 2018 | B2 |
10219925 | Cully et al. | Mar 2019 | B2 |
20020038144 | Trout | Mar 2002 | A1 |
20020099431 | Armstrong et al. | Jul 2002 | A1 |
20020161377 | Rabkin | Oct 2002 | A1 |
20020161427 | Rabkin | Oct 2002 | A1 |
20020188344 | Bolea | Dec 2002 | A1 |
20030004560 | Chobotov | Jan 2003 | A1 |
20030135257 | Taheri | Jul 2003 | A1 |
20030135269 | Swanstrom | Jul 2003 | A1 |
20030199966 | Shiu | Oct 2003 | A1 |
20030225446 | Hartley | Dec 2003 | A1 |
20040044395 | Nelson | Mar 2004 | A1 |
20040087965 | Levine | May 2004 | A1 |
20040093058 | Cottone | May 2004 | A1 |
20040093063 | Wright | May 2004 | A1 |
20040138734 | Chobotov et al. | Jul 2004 | A1 |
20040143316 | Spiridigliozzi | Jul 2004 | A1 |
20040147939 | Rabkin | Jul 2004 | A1 |
20040210298 | Rabkin | Oct 2004 | A1 |
20040220655 | Hartley | Nov 2004 | A1 |
20040230287 | Hartley et al. | Nov 2004 | A1 |
20040260383 | Honda | Dec 2004 | A1 |
20050038495 | Greenan | Feb 2005 | A1 |
20050060018 | Ditman | Mar 2005 | A1 |
20050085890 | Rasmussen | Apr 2005 | A1 |
20050090834 | Chiang | Apr 2005 | A1 |
20050107862 | Ohlenschlaeger | May 2005 | A1 |
20050119722 | Styrc | Jun 2005 | A1 |
20050182290 | Lau | Aug 2005 | A1 |
20050182476 | Hartley et al. | Aug 2005 | A1 |
20060004433 | Greenberg et al. | Jan 2006 | A1 |
20060036314 | Perez | Feb 2006 | A1 |
20060155363 | LaDuca | Jul 2006 | A1 |
20060184226 | Austin | Aug 2006 | A1 |
20060190075 | Jordan | Aug 2006 | A1 |
20060229699 | Tehrani | Oct 2006 | A1 |
20060259119 | Rucker | Nov 2006 | A1 |
20060259122 | Eliseev | Nov 2006 | A1 |
20060276872 | Arbefeuille | Dec 2006 | A1 |
20070010875 | Trout | Jan 2007 | A1 |
20070016281 | Melsheimer | Jan 2007 | A1 |
20070043425 | Hartley | Feb 2007 | A1 |
20070043432 | Christensen | Feb 2007 | A1 |
20070088424 | Greenberg | Apr 2007 | A1 |
20070100427 | Perouse | May 2007 | A1 |
20070142894 | Moore | Jun 2007 | A1 |
20070225797 | Krivoruhko | Sep 2007 | A1 |
20070233223 | Styrc | Oct 2007 | A1 |
20080082154 | Tseng et al. | Apr 2008 | A1 |
20090048656 | Wen | Feb 2009 | A1 |
20100049293 | Zukowski et al. | Feb 2010 | A1 |
20100049294 | Zukowski et al. | Feb 2010 | A1 |
20140330368 | Gloss et al. | Nov 2014 | A1 |
20190192323 | Cully et al. | Jun 2019 | A1 |
Number | Date | Country |
---|---|---|
0664107 | Jul 1995 | EP |
0956833 | May 2000 | EP |
1842508 | Jun 2009 | EP |
1923024 | Jul 2009 | EP |
2896405 | Jul 2007 | FR |
2005179587 | Jul 2005 | JP |
2005537107 | Dec 2005 | JP |
2008119481 | May 2008 | JP |
WO-1995001761 | Jan 1995 | WO |
WO-1997003624 | Feb 1997 | WO |
WO-2001060285 | Aug 2001 | WO |
WO-2004021932 | Mar 2004 | WO |
WO-2005079705 | Sep 2005 | WO |
2006005082 | Jan 2006 | WO |
WO-2006134258 | Dec 2006 | WO |
WO-2007025101 | Mar 2007 | WO |
WO-2008029296 | Mar 2008 | WO |
WO-2008042266 | Apr 2008 | WO |
Entry |
---|
International Search Report and Written Opinion from PCT/US2009/003383, dated Sep. 17, 2009, 12 pages. |
International Search Report and Written Opinion from PCT/US2009/003400, dated Aug. 21, 2009, 11 pages. |
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2009/003383, dated Dec. 16, 2010, 8 pages. |
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2009/003400, dated Dec. 16, 2010, 9 pages. |
Number | Date | Country | |
---|---|---|---|
20180193178 A1 | Jul 2018 | US |
Number | Date | Country | |
---|---|---|---|
61058770 | Jun 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14531697 | Nov 2014 | US |
Child | 15911700 | US | |
Parent | 12478245 | Jun 2009 | US |
Child | 14531697 | US |